170 related articles for article (PubMed ID: 35949145)
1.
Chen Y; Yang X; Liu J; Zhang D; He J; Tang L; Li J; Xiang Q
Nucleosides Nucleotides Nucleic Acids; 2023; 42(2):105-118. PubMed ID: 35949145
[TBL] [Abstract][Full Text] [Related]
2. In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein.
Lin YC; Chen WY; Hwu ET; Hu WP
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628622
[TBL] [Abstract][Full Text] [Related]
3. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
[No Abstract] [Full Text] [Related]
4. Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding.
Alves Ferreira-Bravo I; DeStefano JJ
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696413
[TBL] [Abstract][Full Text] [Related]
5. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
Saify Nabiabad H; Amini M; Demirdas S
Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
[TBL] [Abstract][Full Text] [Related]
6. A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.
Valero J; Civit L; Dupont DM; Selnihhin D; Reinert LS; Idorn M; Israels BA; Bednarz AM; Bus C; Asbach B; Peterhoff D; Pedersen FS; Birkedal V; Wagner R; Paludan SR; Kjems J
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876524
[TBL] [Abstract][Full Text] [Related]
7. RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein.
Adachi T; Nakamura S; Michishita A; Kawahara D; Yamamoto M; Hamada M; Nakamura Y
Biochemistry; 2024 Apr; 63(7):906-912. PubMed ID: 38457656
[TBL] [Abstract][Full Text] [Related]
8. DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection.
Martínez-Roque MA; Franco-Urquijo PA; García-Velásquez VM; Choukeife M; Mayer G; Molina-Ramírez SR; Figueroa-Miranda G; Mayer D; Alvarez-Salas LM
Anal Biochem; 2022 May; 645():114633. PubMed ID: 35247355
[TBL] [Abstract][Full Text] [Related]
9. Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.
Hameed NS; Arif IS; Al-Sudani BT
J Adv Pharm Technol Res; 2023; 14(3):185-190. PubMed ID: 37692001
[TBL] [Abstract][Full Text] [Related]
10. A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
Minagawa H; Sawa H; Fujita T; Kato S; Inaguma A; Hirose M; Orba Y; Sasaki M; Tabata K; Nomura N; Shingai M; Suzuki Y; Horii K
Biochem Biophys Res Commun; 2022 Jul; 614():207-212. PubMed ID: 35617879
[TBL] [Abstract][Full Text] [Related]
11. A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response.
Kim W; Song ES; Lee SH; Yang SH; Cho J; Kim SJ
Sci Rep; 2024 Mar; 14(1):7516. PubMed ID: 38553521
[TBL] [Abstract][Full Text] [Related]
12. Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection.
Rahman MS; Han MJ; Kim SW; Kang SM; Kim BR; Kim H; Lee CJ; Noh JE; Kim H; Lee JO; Jang SK
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375202
[TBL] [Abstract][Full Text] [Related]
13. A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism*.
Schmitz A; Weber A; Bayin M; Breuers S; Fieberg V; Famulok M; Mayer G
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10279-10285. PubMed ID: 33683787
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
Song Y; Song J; Wei X; Huang M; Sun M; Zhu L; Lin B; Shen H; Zhu Z; Yang C
Anal Chem; 2020 Jul; 92(14):9895-9900. PubMed ID: 32551560
[TBL] [Abstract][Full Text] [Related]
15. A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern.
Zhang Z; Li J; Gu J; Amini R; Stacey HD; Ang JC; White D; Filipe CDM; Mossman K; Miller MS; Salena BJ; Yamamura D; Sen P; Soleymani L; Brennan JD; Li Y
Chemistry; 2022 Mar; 28(15):e202200078. PubMed ID: 35084794
[TBL] [Abstract][Full Text] [Related]
16. Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.
Li J; Zhang Z; Gu J; Stacey HD; Ang JC; Capretta A; Filipe CDM; Mossman KL; Balion C; Salena BJ; Yamamura D; Soleymani L; Miller MS; Brennan JD; Li Y
Nucleic Acids Res; 2021 Jul; 49(13):7267-7279. PubMed ID: 34232998
[TBL] [Abstract][Full Text] [Related]
17. One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS-CoV-2.
Li J; Zhang Z; Amini R; Li Y
ChemMedChem; 2022 Jul; 17(13):e202200166. PubMed ID: 35491395
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection.
Kacherovsky N; Yang LF; Dang HV; Cheng EL; Cardle II; Walls AC; McCallum M; Sellers DL; DiMaio F; Salipante SJ; Corti D; Veesler D; Pun SH
Angew Chem Int Ed Engl; 2021 Sep; 60(39):21211-21215. PubMed ID: 34328683
[TBL] [Abstract][Full Text] [Related]
19. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Villa A; Brunialti E; Dellavedova J; Meda C; Rebecchi M; Conti M; Donnici L; De Francesco R; Reggiani A; Lionetti V; Ciana P
Pharmacol Res; 2022 Jan; 175():105982. PubMed ID: 34798263
[TBL] [Abstract][Full Text] [Related]
20. Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.
Devi A; Chaitanya NSN
Mol Divers; 2022 Feb; 26(1):157-169. PubMed ID: 33389440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
